Osteoarthritis Biologic Therapy
Osteoarthritis
Phase 2bActive
Key Facts
About Ageless Biotech
Ageless Biotech is a private, pre-revenue company founded in 2019 and based in San Francisco, operating in the cell and gene therapy sector. Its core technology involves proprietary processing of adipose (fat) and 'discardable' afterbirth tissues to create potent biologic products aimed at treating all forms of osteoarthritis through intra-articular injection. The company is on the cusp of initiating a Phase 2b clinical trial, leveraging a team with extensive FDA regulatory and clinical development experience to advance its pipeline.
View full company profileTherapeutic Areas
Other Osteoarthritis Drugs
| Drug | Company | Phase |
|---|---|---|
| MSC‑OA | Advancells | Phase 1 |
| Osteoarthritis program | Risen Pharma Tech | Clinical (China & US) |
| ViscoCell™ for Osteoarthritis | Likarda | Pre-clinical |
| PKM-011 | PK MED | Pre-clinical |
| CYT-108 | Cytonics | Phase 2 |
| Topical PSGAG | ADORA Life Science | Pre-clinical |
| FGF18 Gene Therapy | Remedium Bio | Pre-clinical |
| MOTYS™ | Doron Therapeutics | Phase 3 |
| Osteoarthritis Treatment Program | Biovico | Pre-clinical |
| aGF | Scarcell Therapeutics | Phase 1 |
| Cartilage Repair | Sayenza Biosciences | Clinical |
| BRM521 | BRIM Biotechnology | Preclinical |